Latest in Wegovy Weight Loss
Sort by
542 items
-
The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research
Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide — while adding great heft to the economy of Novo Nordisk’s home country, Denmark.Top stories - CBS News - November 4 -
Ozempic, Wegovy popularity leads to rise of fake weight loss drugs
The demand for weight loss drugs like Ozempic and Wegovy has led to a flood of fake drugs hitting the market. However, these counterfeit medicines can be harmful to people's health. Tom Hanson has ...Top stories - CBS News - November 9 -
Not just for weight loss: Wegovy may help curb alcohol addiction
The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA Psychiatry suggests.Top stories - NBC News - 6 days ago -
Novo Nordisk Launches Wegovy Weight-Loss Drug in China
The first prescription for the drug in China will reportedly be issued at a public hospital in Shanghai this week and will cost about $193 for a one-month supply of the lowest starter dose.Business - The Wall Street Journal - 14 hours ago -
Nurse’s death linked to approved weight-loss drug
Susan McGowan from North Lanarkshire died two weeks after taking the drug tirzepatide, brand name Mounjaro.Top stories - BBC News - November 8 -
Lilly's weight loss drug shortage deemed over, but hurdles remain
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.Top stories - CBS News - October 23 -
Shares in weight-loss drugmaker Eli Lilly fall on disappointing sales
US group revises down upper end of full-year revenue estimatesBusiness - Financial Times - October 30 -
Hoping for a weight-loss pill? It could get closer to reality next week.
Viking Therapeutics Inc.’s stock rose 2% Friday as excitement continued to build about data on its oral weight-loss drug the company will present at the upcoming Obesity Week event.Business - MarketWatch - November 2 -
Weight loss drug industry injects wealth into Novo Nordisk home country
Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great heft to the economy of Novo Nordisk's home country, Denmark.Top stories - CBS News - November 3 -
Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial
The stock, which enjoys the unusual position of having all buy ratings from the 13 analysts offering coverage on FactSet, has been on a tear this year, gaining 270% to date in 2024.Business - MarketWatch - November 4 -
Counterfeit weight loss drugs sold online as demand for cheaper options grows
A surge in counterfeit versions of popular weight loss drugs is raising health concerns. U.S. Customs is intercepting fake medications with potentially harmful effects. Tom Hanson reports on the ...Top stories - CBS News - November 8 -
Counterfeit weight loss drugs feed demand for cheaper options
Record demand for Ozempic, Wegovy and other weight loss drugs is fueling a surge of dangerous knockoffs.Top stories - CBS News - November 8 -
Mother-of-two dies during Turkey weight-loss op
Janet Savage paid £2,750 for the procedure but stopped breathing during surgery.Top stories - BBC News - November 11 -
Surging diabetes rate underscores vast opportunity in weight-loss drugs
The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according to new data released in The Lancet on World Diabetes Day.Business - MarketWatch - 5 days ago -
RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.
The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply lower Friday, after President-elect Donald Trump named Robert F. Kennedy ...Business - MarketWatch - 3 days ago -
Employers Get Pressure to Pay for Drugs Like Wegovy
Eli Lilly and Novo Nordisk representatives get face time with companies in hopes they will cover their weight-loss drugs.Business - The Wall Street Journal - 18 hours ago -
Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug looms
Viking Therapeutics Inc.’s stock soared 18% Thursday, after the biotech, which is developing a weight-loss drug in pill form that has raised high hopes among analysts and investors, posted earnings ...Business - MarketWatch - October 24 -
AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors
AstraZeneca PLC shed £15 billion in market capitalization on Tuesday, after investors were underwhelmed by early data from a trial of a weight-loss pill.Business - MarketWatch - November 5 -
Amgen says no concerns around weight loss drug’s bone density data after stock falls
Analysts chewed over early data showing the highest dose of Amgen's MariTide was linked to roughly 4% loss of bone mineral density over 12 weeks.Business - CNBC - 6 days ago -
Venom Helped Create Weight-Loss Drugs. What Else Could It Do For Us?
A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the beginning.Science - The New York Times - 5 days ago -
Venom Helped Create Weight-Loss Drugs. What Else Could It Do For Us?
A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the beginning.Science - The New York Times - 5 days ago -
Novo Nordisk's Wegovy Sales Beat Expectations
The pharmaceutical giant’s blockbuster weight-loss drug beat sales expectations in the third quarter, sending shares higher in early trade.Business - The Wall Street Journal - November 6 -
Ozempic and Wegovy Ease Knee Osteoarthritis Pain in Large Study
A large trial showed that semaglutide, sold as Ozempic for diabetes and as Wegovy for obesity, was better than any current medications in alleviating symptoms.Health - The New York Times - November 1 -
Ozempic and Wegovy considered 'available' after more than 2 years in shortage
The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years of being considered in shortage by the Food and Drug Administration (FDA). ...Politics - The Hill - October 30 -
Wegovy's creator invested £6bn in this town. So why is it not booming?
Europe's most valuable company has invested billions in Kalundborg on Denmark's coast - but it has many problems.Top stories - BBC News - November 3 -
How a love story launched the company behind Ozempic, Wegovy
Novo Nordisk, the pharma giant behind Ozempic and Wegovy, has surprising love story origins. The founders, a married couple, were looking for a way to tackle diabetes, which the wife suffered from.Top stories - CBS News - November 3 -
Novo Nordisk shares jump 8% after Wegovy sales beat expectations
Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations and narrowed its 2024 full-year growth guidance.Business - CNBC - November 6 -
Ozempic and Wegovy may be beneficial in fighting alcohol addiction: Study
The weight loss drugs Ozempic and Wegovy may be beneficial for people struggling with alcohol addiction, a study published Wednesday in JAMA Psychiatry said. The study examined about 228,000 people ...Politics - The Hill - 6 days ago -
Meta makes its MobileLLM open for researchers, posting full weights
Developers and researchers interested in testing MobileLLM can now access the models on Hugging Face, fully integrated with the Transformers library.Tech - VentureBeat - October 31 -
-
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
The Danish drugmaker Novo Nordisk argues that semaglutide, the active ingredient in Ozempic and Wegovy, are too complex for those manufacturers to make safely.Business - CNBC - October 23 -
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
It is a sign that Novo Nordisk's efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to skyrocket in the U.S.Business - CNBC - October 30
